OliX PharmaceuticalsI Current Valuation vs. Beta
| 226950 Stock | 45,900 2,350 4.87% |
For OliX PharmaceuticalsI profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OliX PharmaceuticalsI to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OliX PharmaceuticalsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OliX PharmaceuticalsI's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OliX PharmaceuticalsInc over time as well as its relative position and ranking within its peers.
OliX |
OliX PharmaceuticalsInc Beta vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. OliX PharmaceuticalsInc is the top company in current valuation category among its peers. It also is number one stock in beta category among its peers . The ratio of Current Valuation to Beta for OliX PharmaceuticalsInc is about 581,418,327,261 . Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.OliX Current Valuation vs. Competition
OliX PharmaceuticalsInc is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is presently estimated at about 4.51 Trillion. OliX PharmaceuticalsI retains roughly 576.53 Billion in current valuation claiming about 13% of stocks in Biotechnology industry.
OliX Beta vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
OliX PharmaceuticalsI |
| = | 576.53 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
OliX PharmaceuticalsI |
| = | 0.99 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
OliX Beta Comparison
OliX PharmaceuticalsI is currently under evaluation in beta category among its peers.
Beta Analysis
OliX PharmaceuticalsI returns are very sensitive to returns on the market. As the market goes up or down, OliX PharmaceuticalsI is expected to follow.
OliX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on OliX PharmaceuticalsI. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OliX PharmaceuticalsI position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OliX PharmaceuticalsI's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in OliX PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Use Investing Themes to Complement your OliX PharmaceuticalsI position
In addition to having OliX PharmaceuticalsI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in OliX Stock
To fully project OliX PharmaceuticalsI's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OliX PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OliX PharmaceuticalsI's income statement, its balance sheet, and the statement of cash flows.